Guru Teg Bahadur Sahib Charitable Hospital

Name :

Guru Teg Bahadur Sahib Charitable Hospital

Address  :

Shastri Nagar,
Model Town

Town  :

Ludhiana

State  :

Punjab

Country  :

INDIA

Post Code:

141002

Phone  :

+91-161 – 2453916 , 917, 918

Fax  :

+91-161 – 4636168

Web URL  :

Guru Teg Bahadur Sahib Charitable Hospital


Doctors Of Guru Teg Bahadur Sahib Charitable Hospital
Physician
Qualification
Availability
Ajay Dhawan
M.S., M.Ch (Neurosurgery)
On Visit
ALPANA SINGH
BDS
Resident
ARVIND KAUR KHURANA
M.B.B.S., MD (Pathology )
Resident
Ashwani
M.B.B.S
Resident
BAKHSHIS SINGH
B.D.S, M.D.S. ( Pacdodontics and preventive dentistry )
Resident
GAGANJOT KAUR
MBBS. , MD ( Dermatology , Venerology , Leprology )
Resident
Gurpreet Kaur
M.Sc( Microbiologist)( May-2011) PAU, Ludhiana
Resident
Harinder Singh
M.D Paediatrics, Visiting Consultant
Resident
HARISH SEHGAL
M.D. Medicine
Resident
HARPAL SINGH SAHOTA
M.B.B.S.
Resident
ISH KUMAR GARG
M.B.B.S , MS , MCh
Resident
Jagdeep Madaan
M.B.B.S., M.S.(Ortho) (July 1993) S.P. Medical College, Bikaner
Resident
JAGDIP MADAAN
M.B.B.S , M.S ( ORTHO )
Resident
KANWARPREET SINGH
MBBS – B. J. MEDICAL COLEGE , PUNE M.D. (Radiodiagnosis ) : AFMC , PUNE -1995
Resident
Karanveer Singh
B.D.S., M.D.S. Padodontics & Preventive Dentistry (June 2012), S.D.M. College of Dental Scieneces & Hospital,Dharwad, Karnataka.
Resident
KARANVEER SINGH SALUJA
B.D.S. , M.D.S.
Resident
KULJIT KAUR
Bachelor in Physiotherapy
Resident
MAMTA DUTTA
M.Sc ( Biochemistry )
Resident
MANISH NARAD
M.S ( ENT )
Resident
Navjot Kaur Kaler
MBBS, M.D (Paediatrics) (June- 2012) DMC & Hospital, Ludhiana.
Resident
Liver cancer emerges as fast growing threat in country

Liver cancer is emerging as one of the fastest spreading cancers in India We get about 10 new liver cancer cases in our hospital every week and in the past two years we have seen 360 people suffering from liver cancer said Dr SK Sarin director ILBS during a twoday April 78 international symposium organised by the institute on liver cancer in the Ca... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More